lung carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. age at 18-75; 2. no selection on gender; 3. peripheral lung nodule; 4. diameters of nodule <3cm; 5. diagnosis of lung carcinoma; 6. lobes or segments resection + lymph node dissection, by VATS; 7. agree to the study;
Exclusion criteria
Exclusion criteria: 1. Patients with incomplete perioperative medical records; 2. Patients undergoing thoracotomy due to pleural atresia or hemorrhage during VATS operation; 3. Patients with VATS pneumonectomy or wedge-shaped resection; 4. Pulmonary tuberculosis, severe pneumonia, bronchiectasis and other chronic lung diseases; 5. Preoperative combination of malignant tumors in other sites (not including cured); 6. Complicated with serious diseases of heart, lung, kidney, brain, blood and neuropsychiatric system; 7. Poorly controlled hypertension or other systemic diseases; 8. Patients with indwelling chest tube due to pneumothorax or pleural effusion before surgery; 9. Multiple lesions require simultaneous surgery; 10. Severe coagulation dysfunction; 11. Hypoproteinemia (ALB < 25g/L) and severe malnutrition; 12. Patients who have received neoadjuvant chemoradiotherapy before surgery; 13. Patients not appropriate in this study judged by researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NRS/VAS score;postoperative volume of drainage;the period of post-operative chest tube drainage; | — |
Secondary
| Measure | Time frame |
|---|---|
| analgesic consumption;intraoperative bleeding;sleep quality scores;Self-Rating Anxiety Scale;post-operative stays;nflammatory cytokines;lung recruitment;complications;re-catheterization rate;the incision healing rate; | — |
Countries
China
Contacts
Provincial Hospital Affiliated to Shandong First Medical University